Abstract | BACKGROUND:
Honokiol has been known to have antitumour activity. This study was conducted to evaluate the antiproliferative potential of honokiol against the hepG2 heptocellular cell line and its mechanism of action. METHODS: RESULTS: CONCLUSION:
|
Authors | Junfang Deng, Yigang Qian, Lei Geng, Jie Chen, Xiaohui Wang, Haiyang Xie, Sheng Yan, Guoping Jiang, Lin Zhou, Shusen Zheng |
Journal | Liver international : official journal of the International Association for the Study of the Liver
(Liver Int)
Vol. 28
Issue 10
Pg. 1458-64
(Dec 2008)
ISSN: 1478-3231 [Electronic] United States |
PMID | 18507762
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biphenyl Compounds
- Imidazoles
- Lignans
- Pyridines
- Tetrazolium Salts
- Thiazoles
- honokiol
- p38 Mitogen-Activated Protein Kinases
- Caspases
- thiazolyl blue
- SB 203580
|
Topics |
- Apoptosis
(drug effects, physiology)
- Biphenyl Compounds
(pharmacology)
- Blotting, Western
- Carcinoma, Hepatocellular
- Caspases
(metabolism)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Flow Cytometry
- Humans
- Imidazoles
- Lignans
(pharmacology)
- Pyridines
- Signal Transduction
(physiology)
- Tetrazolium Salts
- Thiazoles
- p38 Mitogen-Activated Protein Kinases
(metabolism)
|